Latest Reimbursement News

Horizon Oil and its joint venture partners have signed a binding Letter of Intent with Northern Territory’s Power and Water Corporation to fast-track drilling of two new wells at Mereenie, aiming to secure long-term gas supply agreements through 2034.

Artrya Limited has begun generating fee-per-scan revenues from its Salix Coronary Plaque module at Tanner Health in the U.S., marking a key commercial milestone for the AI-powered cardiac imaging platform.

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

Medallion Metals and IGO Limited have agreed to extend the deadline for completing the Forrestania Nickel Operation acquisition, allowing more time to meet key conditions and secure environmental approvals.

Matsa Resources has received an early A$1.5 million option fee payment from AngloGold Ashanti, reinforcing the latter’s commitment to the Lake Carey Gold Project and bringing total payments to A$7.2 million to date.

Artrya Limited has landed a significant three-year commercial agreement with Northeast Georgia Health System, marking its second U.S. customer for the AI-powered Salix platform. This deal accelerates Artrya’s footprint in cardiovascular diagnostics across a major U.S. health network.

Pacific Edge appoints Simon Flood as chairman designate, aiming to leverage his global investment expertise to navigate Medicare reimbursement challenges for its bladder cancer diagnostic tests in the US.

4DMedical has expanded its partnership with Philips, securing a US$10 million order commitment to distribute its CT – VQ™ lung imaging technology across North America, aiming to transform pulmonary diagnostics.

Chariot Resources has amended its acquisition agreement for a Nigerian lithium portfolio, securing financing and extending the closing deadline to May 2026. The move reinforces exclusivity protections and paves the way for a smoother transaction completion.

BCAL Diagnostics has secured national ethics approval to establish a large-scale registry tracking the clinical impact of its BREASTESTplus blood test for breast cancer diagnosis, aiming to enhance doctor adoption and reimbursement prospects.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

APA Group has entered a joint development agreement with CS Energy to build and own a 400MW gas peaking power plant in Queensland, aiming to bolster energy security and support renewable integration by 2028.